
Guerbet is a limited liability company incorporated under the laws of France with securities listed on Euronext Paris, France. Consequently, our corporate governance framework reflects the mandatory provisions of French corporate law, the securities laws and regulations applying to Guerbet as a corporation listed in France States. In addition, the Company’s corporate governance principles refer to the AFEP-MEDEF Code.
On May 21, 2010, Guerbet adopted the French form of a joint stock company governed by a Board of Directors (Société Anonyme à Conseil d'administration). This legal structure upholds a clear separation between management functions assumed by the Executive Committee and the functions of oversight assured by the Board of Directors, which represents the shareholders.
Board of Directors

Marie-Claire Janailhac-Fritsch
Chairwoman of the Board

Marion Barbier
Director

Mark Fouquet
Director

Eric Guerbet
Director

Didier Izabel
Director

Céline Lamort
Director

Nicolas Louvet
Director

Claire Massiot-Jouault
Director

Isabelle Raynal
Employee Director

Jean-Sébastien Raynaud
Employee Director

Thibault Viort
Director
Executive Committee

David Hale
Chief Executive Officer

Gitte Hesselholt
Chief Commercial Officer Americas & EMEA

Mathieu Elie
Chief Commercial Officer Asia Pacific

Valérie Brissart
Diagnostic Imaging VP

Jean-François Blanc
Interventional Imaging VP

Claire Corot
Research, Innovation & Business Development VP

Philippe Bourrinet
Development, Medical & Regulatory Affairs VP

François Nicolas
Chief Digital Officer & Contrast Injection Systems R&D VP

Jérôme Estampes
Chief Financial Officer

Pétra Zalabak
Human Resources & Health, Safety and Environment VP

Pierre André
Chief Pharmaceutical Officer, Deputy CEO